Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 21, 2022 - Issue 12
Submit an article Journal homepage
1,754
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trial

Yoichiro Hashimotoa Department of Neurology, Kumamoto City Hospital, Kumamoto, JapanView further author information
,
Mika Komorib Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, JapanCorrespondence[email protected]
View further author information
,
Yuka Tanjib Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, JapanView further author information
,
Akichika Ozekib Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, JapanView further author information
&
Koichi Hiratac Headache Center, Dokkyo Medical University, Mibu, JapanView further author information
Pages 1495-1503 | Received 16 Feb 2022, Accepted 12 May 2022, Published online: 24 Jun 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shigekazu Kitamura, Noboru Imai, Yuka Tanji, Akichika Ozeki & Mika Komori. (2023) Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study. Journal of Pain Research 16, pages 1725-1738.
Read now

Articles from other publishers (2)

Masahito Katsuki, Yasuhiko Matsumori, Junko Kawahara, Chinami Yamagishi, Akihito Koh, Shin Kawamura, Kenta Kashiwagi, Tomohiro Kito, Masato Oguri, Shoji Mizuno, Kentaro Nakamura, Katsushi Hayakawa, Osamu Ohta, Noa Kubota, Hina Nakamura, Jun Aoyama, Isamu Yamazaki, Satoshi Mizusawa, Yasuhide Ueki, Maiko Nanri, Yuki Miyakoshi, Shuto Gobo, Akio Entani, Toshiko Yamamoto, Miyako Otake, Takashi Ikeda, Mitsuhiro Matsuo & Fuminori Yamagishi. (2023) Headache education by leaflet distribution during COVID ‐19 vaccination and school‐based on‐demand e‐learning: Itoigawa Geopark Headache Awareness Campaign . Headache: The Journal of Head and Face Pain 63:3, pages 429-440.
Crossref
Takao Takeshima, Kaname Ueda, Mika Komori, Anthony J. Zagar, Yongin Kim, Dena H. Jaffe, Yasuhiko Matsumori & Koichi Hirata. (2022) Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study. Advances in Therapy 39:11, pages 5176-5190.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.